WBB Securities Upgrades Redhill Biopharma (RDHL) to Buy
Tweet
Share
E-mailGet Alerts RDHL Hot Sheet
Price: $4.84 --0%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 30
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 30
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
WBB Securities analyst Steve Brozak upgraded Redhill Biopharma (NASDAQ: RDHL) from Speculative Buy to Buy with a price target of $17.00 (from $9.00).
For an analyst ratings summary and ratings history on Redhill Biopharma click here. For more ratings news on Redhill Biopharma click here.
Shares of Redhill Biopharma closed at $8.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Lululemon Athletica Inc. (LULU) to Buy
- Aurelia Metals Ltd (AMI:AU) PT Raised to AUD0.25 at Macquarie
- Nickel Industries Ltd (NIC:AU) (NICMF) PT Lowered to AUD0.92 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
